Ramos

Burkitt's lymphoma, B lymphocyte

Cell Type:
B cell
Tissue Origin:
Species:
human
Research Area:
Cancer Research/Cell Biology
Immunotherapy / Hematology
Cell Characteristics:
Suspension

Transfection Information

Lonza Optimized Protocol
Optimization Guideline
Filter:
The table below shows data for the cell type and Nucleofector™ Platform selected. Those data are either based on Lonza Optimized Protocols or on results shared from customers who performed an optimization based on our guidelines. In case no data are shown for the selected Nucleofector™ Platform, please take a look at our optimization strategy to get further guidance on how to easily determine optimal Nucleofection conditions yourself.
Protocol Kit Program Cells Efficiency Viable Cells Substrate Format Platform
SG CA-137 2e6 51% 75-79% Plasmid (general) 2 µg 100 µl 4D X-Unit
SG CA-137 4e5 39-41% 69-71% Plasmid (general) 400 ng 20 µl 4D X-Unit
V O-006 2e6 20-34% 67-77% Plasmid (general) 2 µg 100 µl I/II/2b
SG CA-137 5e5 20-30% 70-86% siRNA 20 µl 96-well
SG CM-138 5e5 20-30% 70-86% siRNA 20 µl 96-well

Citations

Categories:
Transfection 
Authors:
Ingle GS, Chan P, Elliott JM, Chang WS, Koeppen H, Stephan JP, Scales SJ 
In:
Br J of Haematol (2008) 140(1): 46-58 
Categories:
Transfection 
Authors:
Sundberg TB, Ney GM, Subramanian C, Opipari AW Jr and Glick GD 
In:
Cancer Res (2006) 66(3): 1775-1782 
Categories:
Transfection 
Authors:
Kim YJ, Sekiya F, Poulin B, Bae YS and Rhee SG 
In:
Mol Cell Biol (2004) 24(22): 9986-9999 
Categories:
Transfection 
Authors:
Jiang XZ, Toyota H, Yoshimoto T, Takada E, Asakura H, Mizuguchi J 
In:
Apoptosis (2003) 8(5): 509-19